Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Companies  >  All News

News : Companies
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Wanda Sports Group Company Ltd - WSG

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/02/2019 | 07:24pm EST

NEW YORK, Dec. 02, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Wanda Sports Group Company Ltd. (“Canopy” or the “Company”) (NASDAQ:  WSG)  Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

The investigation concerns whether Wanda Sports and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On or around July 25, 2019, Wanda Sports completed its initial public offering (the “IPO” or “Offering”), issuing approximately 23.8 million American Depositary Shares (“ADSs”) priced at $8.00 per share.  Then, on September 9, 2019, Wanda Sports reported its financial results for the second quarter of 2019.  The Company advised investors that total revenue had decreased 30% year-over-year, which Wanda Sports attributed “primarily . . . to decreased revenue from the Digital, Production, Sports Solutions (DPSS) segment.”  Wanda Sports also provided full year 2019 revenue guidance “in the range of €1,008 million to €1,070 million, or down 11% to 5% from 2018.” 

Since the IPO, Wanda’s ADSs have closed as low as $2.78 per share, representing a decline of 65.25% from the Offering price.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com


© GlobeNewswire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Companies"
10:02aPOLARIS : Fans Vote Aledo High School “Polaris' Most Driven Team” in Texas High School Football
BU
10:02aIDERA : ER/Studio Adds Extensive Support for Amazon Redshift
BU
10:02aWOLTERS KLUWER : Integrated Expert Solutions From Wolters Kluwer Help Clausen & Associates CPAs, PC Optimize Their Tax Compliance Practice and Build Tighter Client Advisory Relationships
BU
10:02aCEMAT A/S : No. 12/2019 - Upgrade of the expectation for 2019
AQ
10:02aEBAY : Partners with HyperX and Gamers Outreach for Charity Stream to Benefit Children in Hospitals
PR
10:02aGlobal Cultivators Market 2020-2024 | Evolving Opportunities with AGCO Corp. and BCS America | Technavio
BU
10:01aCHINA EVERGRANDE : Further announcement in relation to the proposed payment of dividend for the financial year of 2018
PU
10:01aYICHANG HEC CHANGJIANG PHARMACEUTICAL : Connected transaction entering into capital contribution agreement
PU
10:01aPURECIRCLE : Board and Management Changes
PU
10:01aYICHANG HEC CHANGJIANG PHARMACEUTICAL : Announcement on (1) the postponement of the 2019 4th egm; (2) cancellation of resolution on 2019 4th egm; (3) revised notice of 2019 4th egm and revised proxy form; (4) extension of period for closure of register of members; and (5) further delay in despatch of circular in relation to the discloseable transaction and connected transaction in relation to the proposed acquisition of the target assets from sunshine lake pharma
PU
Latest news "Companies"